GRFS

Grifols, SA (Ticker: GRFS) is a prominent global player in the pharmaceutical and biotechnology sectors, recognized for its expertise in the development and distribution of life-saving therapies derived from human plasma. Based in Barcelona, Spain, the company operates a robust network of plasma donation centers and state-of-the-art manufacturing facilities, enabling it to address the needs of patients with rare and chronic diseases effectively. Grifols is committed to innovating healthcare solutions and expanding its product portfolio, cementing its position as an essential contributor to the global healthcare landscape.